AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation

Acute myeloid leukemia with inv(3)(q21;q26.2)/ t (3;3)(q21;q26.2) (3q26 AML) is a rare disease with poor prognosis and median survival of

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2018-06, Vol.53 (6), p.683-691
Hauptverfasser:	Halaburda, Kazimierz, Labopin, Myriam, Houhou, Mohamed, Niederwieser, Dietger, Finke, Jürgen, Volin, Liisa, Maertens, Johan, Cornelissen, Jan J., Milpied, Noel, Stuhler, Gernot, Kröger, Nicolaus, Esteve, Jordi, Mohty, Mohamad, Nagler, Arnon
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308 692/699/1541/1990/283/1897 Acute myeloid leukemia Adolescent Adult Aged Blood Bone Marrow Transplantation - methods Cell Biology Europe Female Graft-versus-host reaction Hematology Hematopoietic Stem Cell Transplantation - methods Humans Internal Medicine Leukemia Leukemia, Myeloid, Acute - pathology Leukemia, Myeloid, Acute - therapy Male Medical prognosis Medicine Medicine & Public Health Middle Aged Multivariate analysis Myeloid leukemia Patients Peripheral blood Public Health Rare diseases Remission Stem cell transplantation Stem Cells Survival Transplantation Transplantation Conditioning - methods Transplantation, Homologous - methods Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Acute myeloid leukemia with inv(3)(q21;q26.2)/ t (3;3)(q21;q26.2) (3q26 AML) is a rare disease with poor prognosis and median survival of
ISSN:	0268-3369 1476-5365
DOI:	10.1038/s41409-018-0165-x